Biodesix (BDSX) Invested Capital (2021 - 2024)

Biodesix (BDSX) has 4 years of Invested Capital data on file, last reported at $5.8 million in Q2 2024.

• Quarterly Invested Capital fell 59.91% year-over-year to $5.8 million in Q2 2024, while the trailing twelve-month figure through Mar 2025 was $5.8 million (down 92.21% YoY) and the FY2023 annual result came in at $21.9 million, up 111.36% from the prior year.
• Invested Capital eased to $5.8 million in Q2 2024, from $19.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $21.9 million in Q4 2023 to a low of $5.8 million in Q2 2024.
• A 4-year average of $13.7 million and a median of $13.1 million in 2021 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2023 — Invested Capital jumped 111.36% — and 2024, when it plunged 59.91%.
• Tracing BDSX's Invested Capital over 4 years: stood at $17.8 million in 2021, then tumbled by 41.79% to $10.3 million in 2022, then jumped by 111.36% to $21.9 million in 2023, then tumbled by 73.29% to $5.8 million in 2024.
• The last three Invested Capital figures came in at $5.8 million (Q2 2024), $19.2 million (Q1 2024), and $21.9 million (Q4 2023), per Business Quant data.